Katarina Luptakova - CHIEF MEDICAL OFFICER at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Role
Chief Medical Officer
Issuer context
Issuer symbol
XLO on Nasdaq
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by Katarina Luptakova since 31 May 2025

Holdings reported by Katarina Luptakova for Xilio Therapeutics, Inc.

Form 4 holding CHIEF MEDICAL OFFICER

Xilio Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
33,250
Estimated value
$49,062
Report date
01 Jan 2026
Price
$0.9837
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF MEDICAL OFFICER

Xilio Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
451,885
Estimated value
Report date
31 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Katarina Luptakova for Xilio Therapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .